Headline News

A notable proportion of health care providers plan to reduce or stop providing HIV care over the next half decade, even as the need for such care is expected to rise, results from a quantitative national survey showed.

Adults aged 50 years and older, particularly women, who experienced obstructive sleep apnea appeared to be at higher risk for dementia, according to a new study published in SLEEP Advances.

INDIANAPOLIS — According to research presented at Academy 2024, the addition of high-energy visible, or HEV, filtering to soft contact lenses may improve visual acuity in conditions of atmospheric blue haze.

PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine and director of hepatology at Stanford University, discusses data from the ongoing MAESTRO-NASH trial, which were presented at the ACG Annual Scientific Meeting.

The fire that started at the Marck Industries Recycling Center in Rogers, Arkansas, on Oct. 16 prompted local officials to issue a hazardous smoke warning and advise residents with respiratory problems to shelter indoors.

AlloVir, an allogeneic T cell immunotherapy company, will merge with Kalaris Therapeutics to focus on retinal diseases, according to a press release.

BOSTON — Patients taking benralizumab experienced more asthma exacerbations than patients taking mepolizumab, according to an abstract presented at the CHEST Annual Meeting.

In part one of a three-part Healio exclusive series, experts discussed the need for clinical guidance and evidence for the use of AI to improve cardiovascular outcomes.

A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau pathology test that would assist in the diagnosis of Alzheimer’s disease.

PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine and director of hepatology at Stanford University, highlights a presentation evaluating the use of sodium-glucose cotransporter 2 inhibitors in patients with cirrhosis.